INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials. A place of hope and action, the Susan F. Smith Center for Women's Cancers offers multi-dimensional services to strengthen mind, body, and soul and to help alleviate mental and emotional burdens.

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA is pleased to announce it has made a $10,000 contribution to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute in Boston (MA, USA).

Marc Hamel, Director of US Sales at INTEGRA commented. "During our visit to Dana-Farber Cancer Institute, we learned so much about the incredible work being undertaken at this prestigious patient treatment facility specifically in the area of breast cancer. Empowered by the laboratory community’s enthusiastic response to our PIPETGIRL pipette controller I am delighted that we have reached our first milestone - a $10,000 contribution to Dana-Farber.”"

“We are honored to partner with Integra and truly grateful for their generous support of Dana-Farber’s Susan F. Smith Center for Women’s Cancers,” said Courtney Hadden, associate director, corporate partnerships, Dana-Farber and the Jimmy Fund. “Integra’s commitment is admirable and critical to furthering the important work in research and care for women’s cancers taking place at the Center.”

At the beginning of 2015 - INTEGRA decided to make PIPETGIRL its symbol of its commitment to support breast cancer research. Indeed, the company committed to donate 10 € / $ 15 for every purchase of PIPETGIRL to research institutes dedicated to finding a cure for breast cancer.

The PIPETGIRL pipette controller combines all the essential characteristics for productive work with serological pipettes - precision, speed, ease of use, lightweight operating comfort, long battery life and reliability. The PIPETGIRL Is designed for use with all commercially available glass and plastic serological pipettes in the volume range 1 - 100 ml. Each PIPETGIRL pipette controller comes with a 3-year extended warranty to safeguard your investment.

To register your interest in supporting the global fight against breast cancer and to learn more about the PIPETGIRL pipette controller please visit or contact INTEGRA Biosciences in North / South America on telephone +1-603-578-5800 / email [email protected] or in Europe / Asia on telephone +41-81-286-9530 / email [email protected].

INTEGRA Biosciences ( is a leading provider of high-quality laboratory tools for liquid handling, media preparation, sterilization and cell cultivation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life science markets and medical industry. Today, INTEGRA innovative laboratory products are widely used all around the world. More than ninety distribution-partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA.  INTEGRA is an ISO 9001 certified company.

Dana-Farber Cancer Institute (, a principal teaching affiliate of Harvard Medical School, is world-renowned for its leadership in adult and pediatric cancer treatment and research. Designated as a comprehensive cancer center by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes of Health grant funding.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2019, June 18). INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute. News-Medical. Retrieved on December 02, 2023 from

  • MLA

    INTEGRA Biosciences. "INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute". News-Medical. 02 December 2023. <>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute". News-Medical. (accessed December 02, 2023).

  • Harvard

    INTEGRA Biosciences. 2019. INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute. News-Medical, viewed 02 December 2023,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Advancing neurotoxicity research with INTEGRA pipettes